» Authors » Jiangyong Min

Jiangyong Min

Explore the profile of Jiangyong Min including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 29
Citations 536
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Rong L, Lannen N, Andersen N, Tank E, Min J, Chakraborty T, et al.
Neurology . 2025 Feb; 102(7_supplement_1):3373. PMID: 39977885
Objective: NA. Background: Creutzfeldt-Jakob disease (CJD) is a rapidly progressive, fatal brain disease. Sporadic CJD (sCJD) is the most common subtype without genetic cause. There have been no reports on...
2.
Marto J, Strambo D, Ntaios G, Nguyen T, Wrona P, Escalard S, et al.
J Stroke . 2025 Feb; 27(1):128-132. PMID: 39916463
No abstract available.
3.
Khan M, Miller M, McCarthy P, Tsai J, Merhi W, Berkompas D, et al.
Neurol Clin Pract . 2024 Jun; 14(4):e200319. PMID: 38826798
Background And Objectives: Patent foramen ovale (PFO) is present in approximately 25% of adult population. The prevalence of PFO is high in patients with cryptogenic stroke suggesting paradoxical embolism. PFO...
4.
Chalfoun N, Pierobon J, Rosemas S, Fox J, Albano A, Banno J, et al.
Am Heart J Plus . 2024 Apr; 21:100195. PMID: 38559748
Background: Detection of atrial fibrillation (AF) in patients with embolic stroke of undetermined source (ESUS) is challenging due to its paroxysmal nature. We sought to assess AF detection with an...
5.
Rong L, Lannen N, Tank E, Feistel J, Therasse C, Potluri A, et al.
Front Neurol . 2023 Apr; 14:1134225. PMID: 37021286
Background: Creutzfeldt-Jakob disease (CJD) is a rare, rapidly progressive, and uniformly fatal neurodegenerative disease. The reported incidence of CJD is 1 to 2 per million people worldwide annually, with fewer...
6.
Marto J, Strambo D, Ntaios G, Nguyen T, Herzig R, Czlonkowska A, et al.
Neurology . 2022 Nov; 100(7):e739-e750. PMID: 36351814
Background And Objectives: COVID-19-related inflammation, endothelial dysfunction, and coagulopathy may increase the bleeding risk and lower the efficacy of revascularization treatments in patients with acute ischemic stroke (AIS). We aimed...
7.
Min J, Young G, Umar A, Kampfschulte A, Ahrar A, Miller M, et al.
J Stroke Cerebrovasc Dis . 2022 Nov; 31(12):106859. PMID: 36323165
Background: Neurogenic cardiac impairment can occur after acute ischemic stroke (AIS), but the mapping of the neuroanatomic correlation of stroke-related myocardial injury remains uncertain. This study aims to identify the...
8.
Cencer S, Tubergen T, Packard L, Gritters D, LaCroix H, Frye A, et al.
Neurohospitalist . 2022 Jun; 12(3):504-507. PMID: 35755213
The current standard of practice for patients with acute ischemic stroke treated with intravenous tissue-type plasminogen activator (tPA) requires critical monitoring for 24-hours post-treatment due to the risk of symptomatic...
9.
Nguyen T, Qureshi M, Klein P, Yamagami H, Abdalkader M, Mikulik R, et al.
J Stroke . 2022 Jun; 24(2):256-265. PMID: 35677980
Background And Purpose: Recent studies suggested an increased incidence of cerebral venous thrombosis (CVT) during the coronavirus disease 2019 (COVID-19) pandemic. We evaluated the volume of CVT hospitalization and in-hospital...
10.
Rameez F, Walsh M, Wees N, Ali R, Min J, Tank E, et al.
Neurohospitalist . 2021 Dec; 12(1):137-142. PMID: 34950402
Jamestown canyon virus (JCV) is an arbovirus and is an under-recognized cause of mosquito-borne viral encephalitis. In this report we present a patient who presented with focal neurological deficits. Patient...